BioTime Inc Warrants (Expiring October 1, 2018)
BTX.WS
BTX.WS was delisted on the 26th of September, 2018.
40 hedge funds and large institutions have $51.1K invested in BioTime Inc Warrants (Expiring October 1, 2018) in 2018 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 5 increasing their positions, 7 reducing their positions, and 3 closing their positions.
67% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 3
5% more funds holding
Funds holding: 38 → 40 (+2)
29% less repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 7
61% less capital invested
Capital invested by funds: $131K → $51.1K (-$80K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$1.49K |
| 2 |
Creative Planning
Overland Park,
Kansas
|
+$1.47K |
| 3 |
Wells Fargo
San Francisco,
California
|
+$30 |
| 4 |
Bank of America
Charlotte,
North Carolina
|
+$18 |
| 5 |
PA
Parallel Advisors
San Francisco,
California
|
+$9 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ICM
Ionic Capital Management
New York
|
-$91.4K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$328 |
| 3 |
Barclays
London,
United Kingdom
|
-$17 |
| 4 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$15 |
| 5 |
Morgan Stanley
New York
|
-$8 |
BTX.WS Hedge Fund Activity: Q1 2018 in Review
40 of the 4,373 institutional investors tracked by Wall St. Rank reported a position in BioTime Inc Warrants (Expiring October 1, 2018) (BTX.WS) for Q1 2018, worth a combined $51.1K — down 61% from $131K a quarter earlier.
Buyers outnumbered sellers: 5 funds opened new BTX.WS positions and 3 closed out — a net gain of 2 holders — while 5 added to existing stakes and 7 trimmed.
The largest buyer was UBS Group, adding an estimated $1.49K. The largest seller was Ionic Capital Management, cutting an estimated $91.4K.
- 40 institutional investors held BioTime Inc Warrants (Expiring October 1, 2018) (BTX.WS) as of Q1 2018, up from 38 in Q4 2017.
- Funds reported $51.1K of BioTime Inc Warrants (Expiring October 1, 2018) stock for Q1 2018, down 61% quarter-over-quarter.
- 5 funds opened new BioTime Inc Warrants (Expiring October 1, 2018) positions in Q1 2018 and 3 closed out, a net change of +2 holders.
- The largest BioTime Inc Warrants (Expiring October 1, 2018) buyer in Q1 2018 was UBS Group, an estimated $1.49K added.
- The largest BioTime Inc Warrants (Expiring October 1, 2018) seller in Q1 2018 was Ionic Capital Management, an estimated $91.4K sold.
Based on aggregated 13F filings for Q1 2018.